Ecolab announced that its Purolite resin business, together with Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, announced the commercial launch of Purolite’s DurA Cycle, a protein A chromatography resin for large-scale purification processes. This new affinity resin is being introduced at the BIO International Convention (BIO 2024), being held June 3-6 in San Diego. This latest innovation marks a significant milestone in Purolite’s long-term strategic partnership with Repligen, further solidifying Ecolab’s dedication to driving advancements in the bioprocessing industry.
Ecolab Annual Meeting Results Announced
The Keystone State is getting a new manufacturing site for materials used in pharma drug production.
ST. PAUL, Minn.--(BUSINESS WIRE)--Ecolab Inc. (NYSE:ECL), the global leader in water, hygiene and infection prevention solutions and services, will begin implementing a price increase for all Life Sciences division offerings, effective February 1, 2022, due to the significant and ongoing global supply chain disruptions and cost increases, including those for raw materials, logistics and labor.
(Reuters) -Hygiene company Ecolab Inc on Thursday agreed to buy Purolite, whose technology can be used in mRNA vaccine purification, in a $3.7 billion all-cash deal to add weight to its pharmaceutical-focused business.
SMi Reports: Leading microbiologists and industry experts to meet at SMi 10th Anniversary Pharmaceutical Microbiology conference taking place in London in January 2020.
Enforcement Report - Week of September 2, 2020
Enforcement Report - Week of June 26, 2019
Enforcement Report - Week of April 3, 2019
Enforcement Report - Week of November 28, 2018